Show Key Points
GPAT 2026 Admit Card: The National Board of Examination in Medical Sciences (NBEMS) has released the GPAT 2026 hall ticket today, March 2, 2026. Candidates appearing for the Graduate Pharmacy Aptitude Test on March 7, 2026, can download the admit card through the link available on the official website.
To download the GPAT 2026 admit cards, students are required to visit the official website and log in using their application number and password. The admit card will include the details of candidates along with the exam centre details and the instructions for the exams.
The GPAT 2026 admit card are available for download at nbe.edu.in and natboard.edu.in. Candidates can also check a direct link on this page to download the GPAT 2026 hall tickets.
GPAT 2026 Admit Card - Click Here
How to Download GPAT Admit Card 2026
The GPAT 2026 hall ticket will be available for download on the official website. Students can follow the steps provided below to download the admit card
Step 1: Visit the official website for NBEMS
Step 2: Click on GPAT
Step 3: Click on the admit card link
Step 4: Login with the User ID and Password
Step 5: The GPAT Admit Card will be displayed
Step 6: Download for further reference
DIRECT LINK - GPAT 2026 Hall Ticket
Details Given on the GPAT 2026 Admit Card
The GPAT 2026 admit card is a mandatory document to be carried by students. Along with the admit card candidates are also required to keep a valid ID proof with them. When downloading the hall ticket, students are required to cross-check the following details
- Candidate name
- Roll number
- Name of exam
- Exam centre
- Exam day schedule
- Reporting time
- Instructions for candidates
GPAT 2026 Important Dates and Schedule
Students can check the following table to learn the important dates related to the GPAT 2026 exam:
| Event | Date |
| GPAT 2026 Admit Card release date | March 2, 2026 |
| GPAT 2026 Exam date | March 7, 2026 |
| City Intimation Slip release date | February 24, 2026 |
| GPAT 2026 Result Date | April 2026 (Expected) |

Comments
All Comments (0)
Join the conversation